You are here
Aminosterols as Anti-angiogenic Therapeutics for AMD
Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43EY015971-01
Agency Tracking Number: EY015971
Amount:
$100,000.00
Phase:
Phase I
Program:
SBIR
Solicitation Topic Code:
N/A
Solicitation Number:
PHS2004-2
Timeline
Solicitation Year:
2004
Award Year:
2004
Award Start Date (Proposal Award Date):
N/A
Award End Date (Contract End Date):
N/A
Small Business Information
ATTN: CHRIS SCHNITTKER
5110 CAMPUS DRIVE
PLYMOUTH MEETING, PA
19462
United States
DUNS:
N/A
HUBZone Owned:
No
Woman Owned:
No
Socially and Economically Disadvantaged:
No
Principal Investigator
Name: HSIAOLING Hung
Phone: (610) 941-5656
Email: HHUNG@GENAERA.COM
Phone: (610) 941-5656
Email: HHUNG@GENAERA.COM
Business Contact
Phone: (610) 941-5231
Research Institution
N/A
Abstract
Age-related macular degeneration (AMD) is a public health problem resulting in the loss of independence in a significant number of the elderly population. The most severe form of AMD, wet AMD, is caused by the formation of new blood vessels in the choroid
* Information listed above is at the time of submission. *